Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 6, 2007, Pages

  Li, Shuli ^a   Quarto, Natalina ^a,b   Longaker, Michael T ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Pediatric Surgical Research Laboratory   (United States)

Author keywords

Fibroblast growth factor 2; Mitogenic activity

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PROTEIN ANTIBODY;

ANIMAL CELL; ARTICLE; CALVARIA; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DURA MATER; MITOGENESIS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; CELL PROLIFERATION; DURA MATER; FIBROBLAST GROWTH FACTOR 2; MICE; MITOSIS; OSTEOBLASTS; SIGNAL TRANSDUCTION; SKULL;

MUS;

EID: 37149003459     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00135.2007     Document Type: Article

References (38)

1. Bradley JP, Han VK, Roth DA, Levine JP, McCarthy JG, Longaker MT. Increased IGF-I and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion. Plast Reconstr Surg 104: 129-138, 1999.
2. Chaudhary LR, Avioli LV. Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem Biophys Res Commun 238: 134-139, 1997.
3. Chaudhary LR, Hruska KA. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 81: 304-311, 2001.
4. Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT. Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. J Biol Chem 278: 32005-32013, 2003.
5. Debiais F, Lefevre G, Lemonnier J, Le Mee S, Lasmoles F, Mascarelli F, Marie PJ. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -β-catenin-independent signaling pathway. Exp Cell Res 297: 235-246, 2004.
6. Debiais F, Lemonnier J, Hay E, Delannoy P, Caverzasio J, Marie PJ. Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem 81: 68-81, 2001.
7. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149, 2005.
8. Givol D, Eswarakumar V, Lonai P. Molecular and Cellular Biology of FGF Signaling. Oxford, UK: Oxford Univ. Press, 2003, p. 367-379.
9. Glaser M, Blaine E. Fate of cranial defects secondary to fracture and surgery. Radiology 34: 671, 1940.
10. Greenwald JA, Mehrara BJ, Spector JA, Fagenholz PJ, Saadeh PB, Steinbrech DS, Gittes GK, Longaker MT. Immature versus mature dura mater. II. Differential expression of genes important to calvarial reossification. Plast Reconstr Surg 106: 630-639, 2000.
11. Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Crisera FE, Fagenholz PJ, Bouletreau PJ, Longaker MT. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency. J Bone Miner Res 15: 2413-2430, 2000.
12. Hassler W, Zentner J. Radical osteoclastic craniectomy in sagittal synostosis. Neurosurgery 27: 539-543, 1990.
13. Hobar PC, Schreiber JS, McCarthy JG, Thomas PA. The role of the dura in cranial bone regeneration in the immature animal. Plast Reconstr Surg 92: 405-410, 1993.
14. Iseki S, Wilkie AO, Heath JK, Ishimaru T, Eto K, Morriss-Kay GM. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124: 3375-3384, 1997.
15. Iseki S, Wilkie AO, Morriss-Kay GM. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126: 5611-5620, 1999.
16. Jin L, Hu X, Feng L. NT3 inhibits FGF2-induced neural progenitor cell proliferation via the PI3K/GSK3 pathway. J Neurochem 93: 1251-1261, 2005.
17. Kim BG, Kim HJ, Park HJ, Kim YJ, Yoon WJ, Lee SJ, Ryoo HM, Cho JY. Runx2 phosphorylation induced by fibroblast growth factor-2/ protein kinase C pathways. Proteomics 6: 1166-1174, 2006.
18. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278: 319-326, 2003.
19. Kim HJ, Lee MH, Park HS, Park MH, Lee SW, Kim SY, Choi JY, Shin HI, Kim HJ, Ryoo HM. Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev Dyn 227: 335-346, 2003.
20. Mansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 149: 1297-1308, 2000.
21. Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151: 81-93, 1992.
22. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105: 1085-1093, 2000.
23. Mossaz CF, Kokich VG. Redevelopment of the calvaria after partial craniectomy in growing rabbits: the effect of altering dural continuity. Acta Anat (Basel) 109: 321-331, 1981.
24. Odenius M, Celsus A. Atta Bocker om Lakekonsten. Lund, Sweden: 1906.
25. Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16: 1446-1465, 2002.
26. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292-15297, 1996.
27. Pintucci G, Yu PJ, Sharony R, Baumann FG, Saponara F, Frasca A, Galloway AC, Moscatelli D, Mignatti P. Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2-/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2). J Cell Biochem 90: 1015-1025, 2003.
28. Shimoaka T, Ogasawara T, Yonamine A, Chikazu D, Kawano H, Nakamura K, Itoh N, Kawaguchi H. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J Biol Chem 277: 7493-7500, 2002.
29. Simpson ME, Van Dyke DC, Asling CW, Evans HM. Regeneration of the calvarium in young normal and growth hormone-treated hypophysectomized rats. Anat Rec 115: 615-625, 1953.
30. Sirola K. Regeneration of defects in the calvaria. An experimental study. Ann Med Exp Biol Fenn 38, Suppl 2: 1-87, 1960.
31. Spector JA, Greenwald JA, Warren SM, Bouletreau PJ, Crisera FE, Mehrara BJ, Longaker MT. Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation. Plast Reconstr Surg 109: 631-642, 2002.
32. Spector JA, Greenwald JA, Warren SM, Bouletreau PJ, Detch RC, Fagenholz PJ, Crisera FE, Longaker MT. Dura mater biology: autocrine and paracrine effects of fibroblast growth factor 2. Plast Reconstr Surg 109: 645-654, 2002.
33. Takai S, Tokuda H, Hanai Y, Kozawa O. Activation of phosphatidylinositol 3-kinase/Akt limits FGF-2-induced VEGF release in osteoblasts. Mol Cell Endocrinol 267: 46-54, 2007.
34. Tanaka H, Ogasa H, Barnes J, Liang CT. Actions of bFGF on mitogenic activity and lineage expression in rat osteoprogenitor cells: effect of age. Mol Cell Endocrinol 150: 1-10, 1999.
35. Wang J, Glimcher MJ. Characterization of matrix-induced osteogenesis in rat calvarial bone defects: II. Origins of bone-forming cells. Calcif Tissue Int 65: 486-493, 1999.
36. Yang D, Guo J, Divieti P, Bringhurst FR. Parathyroid hormone activates PKC-δ and regulates osteoblastic differentiation via a PLC-independent pathway. Bone 38: 485-496, 2006.
37. Yu JC, McClintock JS, Gannon F, Gao XX, Mobasser JP, Sharawy M. Regional differences of dura osteoinduction: squamous dura induces osteogenesis, sutural dura induces chondrogenesis and osteogenesis. Plast Reconstr Surg 100: 23-31, 1997.
38. Zhang B, Cao H, Rao GN. Fibroblast growth factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14,15- epoxyeicosatrienoic acid-induced angiogenesis. J Biol Chem 281: 905-914, 2006.